ABSTRACT Low passage Fischer rat embryo cultures, which are normally very resistant to transformation by 3-methyicholanthrene but are highly susceptible when chronically infected with the Rauscher murine leukemia virus, were completely protected from transformation by methylcholanthrene when treated with neutralizing antiby specific for the leukemia virus prior to and during treatment with methylcholanthrene. Sister cultures were not protected by neutralizing antibody specific for the B-tropic radiation leukemia virus. This demonstrates clearly a definite type specific role for Rauscher murine leukemia virus in the 3-methylcholanthrene transformation system in rat cells. We have previously described a Fischer rat embryo cell line that at a low passage level (<60) requires either the addition of an exogenous type-C RNA virus or treatment with an halogenated pyrimidine prior to treatment with a chemical carcinogen in order for transformation to occur (1, 2). At passage levels higher than 60, chemicals known to be carcinogenic in animals do on occasion transform the cells without preinfection by type-C RNA virus. These high passage cells appear to be negative for infectious type-C RNA virus; however, the gs-1 antigen of RaLV (the endogenous type-C RNA rat virus) is often expressed after transformation (2), and the rat type-C virus can be induced in both the low and high passage cells by 5-iodo-2'-deoxyuridine (I. Shif, personal communication). We have recently shown that two agents that inhibit this induction by iododeoxyuridine, namely, streptonigrin (3) and cordycepin (4), protect the rat cells from transformation by the polycyclic hydrocarbon 3-methylcholanthrene. We report here that low passage Fischer rat embryo cultures chronically infected with the Rauscher murine leukemia virus (RLV) are protected from transformation by 3-methylcholanthrene if treated with neutralizing antibody specific for RLV; the cultures were not protected by neutralizing antibody specific for the B-tropic radiation leukemia virus (RadLV) (5), which is Gross-like in its neutralizing antigenic determinants.
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MATERIALS AND METHODS
Reduction in plating efficiency of the chronically infected Fischer rat embryo cells relative to a control serum was used to determine the toxicity of the antisera. Five hundred cells in 5 ml of complete growth medium (Eagle's minimal essential medium in Earle's salts supplemented with 5% dialyzed calf serum, 5% fetal bovine serum, 2 mM L-glutamine, 0.1 mM nonessential amino acids, and a mixture of 100 units of penicillin and 100 ,tg of streptomycin per ml) were added to each 60-mm plastic dish (Lux). After a 4-hr incubation period at 370 (to allow cell attachment) the medium was decanted and replaced with a fresh medium now containing serial, 2-fold dilutions of antisera or control serum. Five days later the cells were fixed and stained (Giemsa) Aig of 3-methylcholanthrene incorporated in media containing fetal bovine serum or fetal bovine serum plus control rabbit serum showed multiple areas of transformed cells seven subcultures after methylcholanthrene treatment. In contrast, the F 119 control cultures and sister cultures treated with the RLV-specific antisera prior to and during treatment with methylcholanthrene were still not transformed 15 subcultures after treatment (Fig. 1) .
Experiment 2
Using the procedure for infectious center assay (8), it was found that about 10% of the F115 cells were actually producing virus at any one time (Table 2) . At a dilution of 1: 960, the difference in relative plating efficiency between RLV and RadLV antisera was only 4% (94% as compared to 98%), but the number of cells able to produce virus averaged only eight per dish after treatment with the anti-RLV as compared to 68 with the anti-RadLV. At a dilution of 1:480 of the goat anti-RLV, the overall plating efficiency was reduced by 22%, but the percentage of cells producing virus was reduced to near 0. Even though the percentage of cells producing virus at any one time was reduced by treatment with specific antibody, cloning experiments showed that every cell still had the ability to produce virus. Dilutions of goat antisera against RLV of 1:480 or 1:960 also reduced supernatant virus and protected the cells from transformation by methylcholanthrene. Cultures still had a normal morphology at the termination of the experiment 15 subcultures after methylcholanthrene treatment (Fig. 2) (id) The antibody may be inhibiting cell division (thus making the cells insensitive to transformation by the chemical carcinogen). We know that this is not the explanation since in the presence of specific antibody there is still an average 5-fold increase in cell number over a seven-day period.
There are two possible mechanisms that would account for our data:
(i) Those cells actively producing virus during the period of carcinogen treatment are the most susceptible to transformation (the virus either providing oncogenic information or combining with and switching on endogenous oncogenic information). The specific inhibition of this select population by the specific antibody would thus be responsible for the inhibition of transformation.
(ii) There is a minimal threshold for virus expression below which there is no transformation; in this case, the specific antisera would reduce virus replicating in dividing cells below the necessary threshold. Either of these models is supported by our observations that specific antibody must be present at the time of carcinogen treatment. When the specific antibody was added subsequent to carcinogen treatment, there was no protection under the conditions of the present study. 
